ArticleNeuro-oncology2022

PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications.

Esraa Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.